Company intelligence / Profile preview

NDR Medical Technology

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

NDR Medical Technology has developed the patented Automated Needle Targeting system ("ANT"), with its flagship product ANT-X receiving FDA clearance as the first automated robotic device to aid needle positioning for percutaneous nephrolithotomy. Clinical trials have shown increased first-attempt success rates by over 40% compared to traditional methods. The company’s technology reduces procedure time and radiation exposure while improving accuracy across multiple interventional specialties.

Therapeutic areas: NeurologyOncologyPulmonologyNephrology
Modalities: DeviceAI-enabled robotic systemImage-guided intervention platform
Industry: Surgical Medical Devices

Partnerships

CGBIO (South Korea)Radboud UMC (Netherlands)Nagoya City University Hospital (Japan)Mount Sinai Hospital (USA)

Beyond the preview

Go deeper on NDR Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NDR Medical Technology.

Explore the full profile